How state policies on substance use treatment affect healthcare use and opioid overdoses in Medicaid patients
Official title: The Effects of States' Substance Use Waivers on Healthcare Utilization and Opioid-related Overdoses Among Medicaid Enrollees with Opioid Use Disorder
Funded at Oregon Health & Science University · NIH-10841552 · Data updated 2026-11-12
This study looks at how different Medicaid rules in each state affect the treatment and recovery of people with opioid use disorder, aiming to find out which policies help more people get the care they need and reduce overdose rates.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project start | July 1, 2021 |
| Project end | May 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $603,203 |
| NIH project number | 5R01DA052388-04 |
| Project ID | NIH-10841552 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Medicaid enrollees diagnosed with opioid use disorder.
✕Less likely to help
Patients who do not have opioid use disorder or are not enrolled in Medicaid may not benefit from this research.
What this research studies
This research investigates the impact of state-level Medicaid policies on the treatment and outcomes of individuals with opioid use disorder (OUD). It focuses on how different state waivers influence healthcare utilization and the rates of opioid-related overdoses among Medicaid enrollees. By analyzing data from various states, the study aims to identify which policies are most effective in improving treatment access and reducing overdose incidents. The findings could help inform better healthcare policies for managing OUD.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare policies that enhance treatment access and reduce opioid overdoses among Medicaid patients.
How similar studies have gone: Previous research has shown that certain state policies can significantly impact treatment outcomes for opioid use disorder, suggesting that this approach has potential for meaningful insights.
Where this research is happening
-
Oregon Health & Science University
Portland, United States Active
Researchers
- Principal investigator: Lindner, Stephan Reinhard — Oregon Health & Science University
- Study coordinator: Lindner, Stephan Reinhard
Related research
Other NIH-funded projects on the same topics.
-
Shame and sexual violence in opioid treatment: daily mood and long-term effects on cravings, use, and care
A research project is studying how feelings of shame and experiences of sexual violence affect cravings, drug use, and engagement in treatment for people undergoing opioid treatment.
-
Understanding the impact of shame on opioid use disorder treatment for sexual violence survivors
This study is looking at how feelings of shame impact people with opioid use disorder who have gone through sexual violence, and it aims to understand how these feelings affect their cravings, substance use, and participation in treatment, so we can find better ways to support them on their recovery journey.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.